Dr. Fakhreddin Jamali

Chief Executive Officer

Dr. Jamali is a Professor at the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta. Prior to accepting Equitech's CEO position, he was the Associate Dean of the Faculty for six year. Dr. Jamali has vast expertise in drug development issues through his years of experience as a consultant and/or board member of many pharmaceutical firms. He is a member of Health Canada's TPD Expert Advisory Committee on Bioavailability and Bioequivalence and also Respiratory and Allergy Committee. He is the founding President of Canadian Society of Pharmaceutical Sciences (CSPS), and the Editor-in-Chief of the Journal of Pharmacy and Pharmaceutical Sciences (http://www.cspscanada.org). Dr. Jamali holds a PhD (pharmacokinetics) and an MSc (pharmaceutics) from the University of British Columbia, Vancouver, Canada, as well as a PharmD from the University of Tehran, Iran. His research interests include the safety and efficacy of drugs such as analgesics, anti-rheumatic, and cardiovascular drugs. He has received numerous prestigious awards including the Killam professorship, the Alberta Centennial Award, the American Association of Pharmaceutical Scientists Fellowship, and the CSPS Leadership Award." For more detail, please see http://www.pharmacy.ualberta.ca/Jamali.htm

Collen Ozee

Chief Financial Officer

Collen Ozee, B.Comm. lends her experience to EquiTech as the Interm Chief Financial Officer, responsible for Annual and Quarterly reporting of financial results and shareholder distributions, along with ensuring all relavant regulatory fillings are accurate and timely. Ms. Ozee has financial and business experience from her role with the Foundation Equity Coropration, an Alberta-based venture capital firm.

Karl Jacob

Account Manager